Soni Savai Pullamsetti

Living human lung slices for ex vivo modelling of lung cancer

Pathology and pathobiology of pulmonary hypertension: current insights and future directions

A Roadmap for Therapeutic Discovery in Pulmonary Hypertension Associated with Left Heart Failure. A Scientific Statement of the Heart Failure Association (HFA) of the ESC and the ESC Working Group on Pulmonary Circulation & Right Ventricular Function

miR-147b mediated suppression of DUSP8 promotes lung cancer progression

Seeing pulmonary hypertension through a paediatric lens: a viewpoint

Spatial profiling of the microenvironment reveals low intratumoral heterogeneity and STK11-associated immune evasion in therapy-naïve lung adenocarcinomas

HIF1α-AS1 is a DNA:DNA:RNA triplex-forming lncRNA interacting with the HUSH complex

Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective

HIF1α-AS1 is a DNA:DNA:RNA triplex-forming lncRNA interacting with the HUSH complex

Hypoxia-inducible factor signaling in pulmonary hypertension

Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non–Small Cell Lung Carcinoma

Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer

Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer

Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ

Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension

Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension

Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis

Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives

Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis

Treatment with low‐dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension

Pathobiology, pathology and genetics of pulmonary hypertension: Update from the Cologne Consensus Conference 2018

Long Noncoding RNA MANTIS Facilitates Endothelial Angiogenic Function

FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis

Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension

Transcription Factors, Transcriptional Coregulators, and Epigenetic Modulation in the Control of Pulmonary Vascular Cell Phenotype: Therapeutic Implications for Pulmonary Hypertension (2015 Grover Conference Series)

Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis

Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma

Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension

Macrophage and Cancer Cell Cross-talk via CCR2 and CX3CR1 Is a Fundamental Mechanism Driving Lung Cancer